tbuckley/cabot-search huggingface dataset:
Home treatment of deep venous thrombosis with low molecular weight heparin: Long‐term incidence of recurrent venous thromboembolism
Authors: Enric Grau, Jose M. Tenias, Esperanza Real, Jose Medrano, Rosario Ferrer, Emilio Pastor, Salvador Selfa
Journal: American Journal of Hematology (2001)

Outpatient treatment of deep venous thrombosis (DVT) with low molecular weight heparin (LMWH) seems as safe and effective as inpatient treatment with unfractionated heparin (UFH). However, most of the randomized trials comparing a LMWH with UFH described clinical outcomes within 3–6 months. The long-term incidence of recurrent VTE after treatment of DVT with LMWH remains to be established. The primary objective of this retrospective study was to document the long-term incidence of recurrent venous thromboembolism (VTE) in patients with DVT treated with a LMWH, nadroparin in an outpatient basis. The patients were evaluated 46 months after inclusion in two cohorts comparing home treatment with nadroparin (n = 130) with in-hospital treatment with intravenous UFH (n = 149). More than 60% of the patients in the nadroparin group could be treated at home, either entirely or after a short stay in hospital. The age-adjusted thrombosis-free survival was not statistically significant between nadroparin and UFH-treated patients (P = 0.084). There was a nonsignificant trend favoring nadroparin as compared with UFH. The hazard ratio (HR) for recurrent VTE in the nadroparin group with respect to the UFH group was 0.44 (95% confidence interval, 0.17–1.12). No significant differences were observed in overall mortality or major hemorrhage between the two treatment groups. Our study suggests that home treatment of DVT with LMWH is at least as effective and safe as in-hospital UFH after a long-term follow-up period. Am. J. Hematol. 67:10–14, 2001. © 2001 Wiley-Liss, Inc.
Arsenical Encephalopathy
Authors: J. S. Hensman
Journal: BMJ (1947)

Co-operation of Obstetricians and Paediatricians SIR,-Reference has been made in recent numbers of the -Journal to the desirability of obstetricians and paediatricians -co-operating in their joint interest in the newborn infant.I should like to emphasize the value of such an experience in the light of the practice in the Belfast Medical School.Every month the obstetricians and paediatricians of the maternity hospitals in Belfast meet to review the obstetric and paediatric problems of the previous month.The audience includes, in addition, the pathologist, anaesthetist, obstetric and paediatric registrars and tutors, senior and junior R.M.O.s, and the appropriate members of the nursing staff.Representatives *of the Ministry of Health and of the Belfast Corporation Maternity and Infant Welfare Department also attend.The programme includes statistics of the number of births, propor- tion of caesarean and forceps deliveries, etc., data relating to maternal and infant mortality and morbidity, as well as details of stillbirths and neonatal deaths.Discussions take place on
Second International Meeting on Immunotherapy of Cancer: Present Status of Trials In Man
Journal: JNCI Journal of the National Cancer Institute (1980)

Second International Meeting on Immunotherapy of Cancer: Present Status of Trials In Man Get access JNCI: Journal of the National Cancer Institute, Volume 64, Issue 1, January 1980, Page 207, https://doi.org/10.1093/jnci/64.1.207-c Published: 01 January 1980
Drug Regulation
Authors: Robert C. Wallach
Journal: JAMA (1976)

<h3>To the Editor.—</h3> The role of governmental agencies in the control of drugs and chemicals is becoming "curiouser and curiouser." Two letters comment on the mixed influence the Food and Drug Administration (FDA) has on the development and use of new medications (235:473, 1976). The subsequent commentary by Dr Kean (235:501, 1976) on the "treatment of amebiasis" prompts me to report some curious interactions related to the use of diiodohydroxyquin. Floraquin, a vaginal suppository containing diiodohydroxyquin, was recently withdrawn from the market by Searle with an absolute minimum of publicity. Unsubstantiated rumor has it that the FDA requested Searle to provide proof of efficacy for this product, which has been available for many years and used widely. It has been suggested that, rather than set up the appropriate studies, the drug was withdrawn. By coincidence, Searle markets metronidazole (Flagyl), also useful for the indication of<i>Trichomonas</i>infection for which the
Précis d'anatomie pathologique.
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Leadership Program Grants Awarded
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Erratum for the Research Article: “A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes” by I. Serr, M. G. Scherm, A. M. Zahm, J. Schug, V. K. Flynn, M. Hippich, S. Kälin, M. Becker, P. Achenbach, A. Nikolaev, K. Gerlach, N. Liebsch, B. Loretz, C.-M. Lehr, B. Kirchner, M. Spornraft, B. Haase, J. Segars, C. Küper, R. Palmisano, A. Waisman, R. A. Willis, W.-U. Kim, B. Weigmann, K. H. Kaestner, A.-G. Ziegler, C. Daniel
Journal: Science Translational Medicine (2019)
Toxic Compensation Bills
Authors: Robert C. Anderson
Journal: Environmental Health Perspectives (1985)

Congress has demonstrated interest in toxic compensation legislation, but not enough agreement to make significant progress. Advocates of reform claim that the legal system is heavily weighed against victims who seek compensation through the courts. Proposed reforms include a compensation fund and a cause of action in federal court. Critics have questioned whether these changes in the law would represent an improvement. Existing income replacement, medical cost reimbursement, and survivor insurance programs largely cover the losses of individuals with chronic disease. Thus, the need for an additional compensation is not clear. Furthermore, experience with compensation funds such as the Black Lung Fund suggests that political rather than scientific criteria may be used to determine eligibility. Finally, under the proposed financing mechanisms the compensation funds that are being debated would not increase incentives for care in the handling of hazardous wastes or toxic substances.
Unintended Consequences
Authors: Ellis M. Knight
Journal: Annals of Internal Medicine (2005)

Letters20 December 2005Unintended ConsequencesEllis M. Knight, MDEllis M. Knight, MDFrom Palmetto Health, Columbia, SC 29203.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-143-12-200512200-00014 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:As a long-time practicing internist and hospitalist who trained well before the recent resident work restrictions, I feel compelled to respond to Dr. Ryan's (1) contention that unintended negative consequences are resulting from the recent changes in resident work schedules. I maintain that these consequences may very well be intended and in fact are constructive when considered in the context of the work environment that housestaff will face in the future.In my 20-plus years of private practice, the health care reimbursement system has forced practitioners like me to push productivity to the limit. Intellectual curiosity must ...Reference1. Ryan J. Unintended consequences: the Accreditation Council for Graduate Medical Education work-hour rules in practice. Ann Intern Med. 2005;143:82-3. [PMID: 15998759] LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Palmetto Health, Columbia, SC 29203.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoUnintended Consequences: The Accreditation Council for Graduate Medical Education Work-Hour Rules in Practice Jason Ryan Unintended Consequences Steven J. Zanders Unintended Consequences Jason Ryan Metrics 20 December 2005Volume 143, Issue 12Page: 917KeywordsConflicts of interestForecastingHealth careHospitalistsHypercalcemiaMemory ePublished: 20 December 2005 Issue Published: 20 December 2005 Copyright & PermissionsCopyright © 2005 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Salami publication.
Authors: M. J. Bennie, C. W. Lim
Journal: BMJ (1992)

occurred more than seven weeks after his admission for self cutting.During five days of inpatient observation he was wary but coherent and rational.Repeated examination found no psychotic signs.With the ward team's agreement he was discharged into intensive community care, was seen repeatedly at his home and at the daily living programme team's base, managed well, and found a job.Two days after last being seen he suddenly killed a child and revealed previously concealed paranoid delusions.Had he remained an inpatient he could have absconded, avoided outpatient follow up, and become someone for whom district services could disclaim responsibility.Community care teams like the daily living programme team which do assertive outreach, however, continue their re- sponsibility for patients and thus their vulnerability to blame for adverse events.Conclusions from our study await our final report.They will have to balance the clinical and social outcomes, patients' and relatives' satisfaction, risk assessment, and an economic analysis.
Funding Acknowledgment Omitted
Journal: JAMA (1981)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Wording Error in Conclusions Section
Authors: Salvatore Rudilosso, Xabier Urra, Ángel Chamorro
Journal: JAMA Neurology (2016)

Salman Farooq, MD; Bradley C. Hiner, MD; William J. Rhead, MD, PhD; Alison La Pean Kirschner, MS, CGC; Thomas C. Chelimsky, MD
Contents
Authors: Jae Lee, Hae-Young Park, Jiwon Baek, Ki Lee, Jacqueline Chua, Gowtham Thakku, Tin Beng, Monisha Tun, Marcus Chiang, Lee Tan, Michael Girard, Tien Wong, Joanne Hui, Min Quah, Tin Aung, Ching-Yu Cheng, Joseph Ciolino, Amy Ross, Rehka Tulsan, Amy Watts, Rong-Fang Wang, David Zurakowski, Janet Serle, Daniel Kohane, Panos Christakis, Jeffrey Kalenak, James Tsai, Jeffrey Kammer, Paul Harasymowycz, Juan Mura, Louis Cantor, I Ahmed, Dorothée Van Trier, Anna Vos, Renske Draaijer, Jos Th, Aarti Patel, Ravi Purohit, Helena Lee, Viral Sheth, Gail Maconachie, Eleni Bmedsci, Rebecca Mclean, Irene Gottlob, Frank Proudlock, Kamron Khan, Farrah Islam, Anthony Moore, Michel Frcophth, Brian Toy, Ira Schachar, Gavin Tan, Darius Moshfeghi, Gui-Shuang Ying, Deborah Vanderveen, Ebenezer Daniel, Graham Quinn, Agnieshka Baumritter, Erin Boese, Nieraj Jain, Yali Jia, Catie Schlechter, Cary Harding, Simon Gao, Rachel Patel, David Huang, Richard Weleber, Melanie Gillingham, Mark Pennesi, Albert Jean-Charles, Harold Merle, Isabelle Audo, Catherine Desoudin, Béatrice Bocquet, Corinne Baudoin, Moro Sidibe, Martine Mauget-Faÿsse, Benjamin Wolff, Agnès Fichard, Guy Lenaers, José-Alain Sahel, Alain Gaudric, Yves Cohen, Christian Hamel, Isabelle Meunier, Sufian Elfandi, Sotaro Ooto, Naoko Ueda-Arakawa, Ayako Takahashi, Munemitsu Yoshikawa, Hideo Nakanishi, Hiroshi Tamura, Akio Oishi, Kenji Yamashiro, Nagahisa Yoshimura, David Sarraf, Nikolas London, Rahul Khurana, Pravin Dugel, Shamika Gune, Lauren Hill, Lisa Tuomi, Marjean Kulp
Journal: Ophthalmology (2016)
SCHOOLBOY MOSQUITO BRIGADES.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Mortality differences and speed of wound closure among specialized burn care facilities
Authors: R. A. Wolfe
Journal: JAMA (1983)

Burn patient mortality rates at 11 major American burn care units were investigated and were found to differ substantially after carefully adjusting for patient mix at each participating burn facility. The adjusted mortality rates differed by as much as a factor of two. Institution speed of full-thickness burn wound closure was found to be significantly associated with mortality experience, with lower mortality associated with quicker wound closure. The data analyzed were from the National Burn Information Exchange (12,000 cases). (<i>JAMA</i>1983;250:763-766)
Sickle cell crisis treated by exchange transfusion. Treatment of two patients with heterozygous sickle cell syndrome
Authors: M. Green
Journal: JAMA (1975)

In two patients with severe painful sickle cell crisis and a deteriorating clinical course, recovery coincided with large-scale exchange transfusions (6 liters). The one patient, with sickle cell β thalassemia, achieved a 90% exchange, calculated on the sickle cell hemoglobin present before and after transfusion. The other patient, with sickle cell hemoglobin (Hb) C disease, also achieved an 80% exchange calculated on the level of Hb A, S, and C in samples before and after transfusion. (<i>JAMA</i>231:948-950, 1975)
Reply
Authors: J.L. Burton, E.M. Saihan
Journal: British Journal of Dermatology (1980)

Journal Article Reply Get access J.L. Burton, J.L. Burton Department of Dermatology, Royal Infirmary, Bristol BS2 8HQ Search for other works by this author on: Oxford Academic Google Scholar E.M. Saihan E.M. Saihan Department of Dermatology, Royal Infirmary, Bristol BS2 8HQ Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 103, Issue 5, 1 November 1980, Page 586, https://doi.org/10.1111/j.1365-2133.1980.tb01678.x Published: 01 November 1980
HEREDITARY HEMOPTYSIS
Authors: EMANUEL LIBMAN
Journal: JAMA (1923)

In 1918 we<sup>1</sup>described a family that presented what appeared to be a new form of hereditary hemorrhagic disease distinct from the two already established forms of bleeding tendency, hemophilia and multiple telangiectases. In this family, seven persons presented almost identical histories of repeated profuse hemoptyses beginning about puberty or in early adult life and occurring at intervals throughout life. We have now kept three bleeders in this family under observation for an additional five years since our first report, (through the courtesy of Dr. S. S. Lubin, their family physician). This makes a total of seven years during which the clinical picture of the condition has been observed and has not changed. We think that this long period of observation is sufficient to exclude tuberculosis. The first member of the family to be seen by us was admitted to the Mount Sinai hospital in 1916, while suffering from
Emergency Ultrasound
Authors: Chad Kessler
Journal: JAMA (2008)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Studies of Chronic Pyelonephritis with Special Reference to the Kidney Function
Journal: JAMA (1949)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Synergistic effects of extracellular vesicle phenotyping and AFP in hepatobiliary cancer differentiation
Authors: Sabine Urban, Hanna Sänger, Marcin Krawczyk, Arnulf Willms, Joanna Ligocka, Mikel Azkargorta, Tudor Mocan, Christoph Kahlert, Robert Schwab, Aliona Wöhler, Maria Angeles Gonzalez-Carmona, Zeno Sparchez, Jesus M. Banales, Christian Strassburg, Piotr Milkiewicz, Veronika Lukacs-Kornek, Miroslaw Kornek
Journal: Journal of Hepatology (2020)
Clinical trial investigators talk about getting the data
Authors: C. Marwick
Journal: JAMA (1997)

WHAT ARE the challenges and the problems involved in conducting clinical trials? To add perspective to the other reports in this section, MEDICAL NEWS asked 3 investigators who are experienced in running, managing, and reviewing clinical trials for their opinion. Darrell Abernethy, MD, is director of the Clinical Research Center at Georgetown University School of Medicine, Washington, DC; William R. Harlan, MD, is associate director for disease prevention at the National Institutes of Health (NIH) in Bethesda, Md; and Robert Temple, MD, is director of the Office of Drug Evaluation 1, Center for Drug Evaluation and Research, at the US Food and Drug Administration, Rockville, Md. <h3>JAMA:</h3> When did clinical trials begin? How have they changed over the years? Have investigators become smarter about the number of subjects needed to ensure statistical significance, for example? <h3>Dr Harlan:</h3> Clinical trials as we know them today may not have started until after